Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MSN LABS PVT LTD

  • FDA Approval
  • Aug. 29, 2022, 17:29 UTC
  • 24
  • 0 comments

FDA approve DARUNAVIR

Comment Full text

ASTRAZENECA

  • FDA Approval
  • Aug. 29, 2022, 10:06 UTC
  • 26
  • 0 comments

FDA approve OLAPARIB

Comment Full text

PFIZER

  • FDA Approval
  • Aug. 29, 2022, 10:00 UTC
  • 26
  • 0 comments

FDA approve DICLOFENAC SODIUM; MISOPROSTOL

Comment Full text

LUPIN

  • FDA Approval
  • Aug. 28, 2022, 11:26 UTC
  • 17
  • 0 comments

FDA approve DASATINIB

Comment Full text

INCYTE CORP

  • FDA Approval
  • Aug. 28, 2022, 11:26 UTC
  • 22
  • 0 comments

FDA approve PEMIGATINIB

Comment Full text

US ANTIBIOTICS

  • FDA Approval
  • Aug. 28, 2022, 11:26 UTC
  • 19
  • 0 comments

FDA approve AMOXICILLIN; CLAVULANATE POTASSIUM

Comment Full text

US ANTIBIOTICS

  • FDA Approval
  • Aug. 28, 2022, 11:26 UTC
  • 21
  • 0 comments

FDA approve AMOXICILLIN; CLAVULANATE POTASSIUM

Comment Full text

US ANTIBIOTICS

  • FDA Approval
  • Aug. 28, 2022, 11:26 UTC
  • 20
  • 0 comments

FDA approve AMOXICILLIN; CLAVULANATE POTASSIUM

Comment Full text

US ANTIBIOTICS

  • FDA Approval
  • Aug. 28, 2022, 11:26 UTC
  • 20
  • 0 comments

FDA approve AMOXICILLIN; CLAVULANATE POTASSIUM

Comment Full text

US ANTIBIOTICS

  • FDA Approval
  • Aug. 28, 2022, 11:26 UTC
  • 20
  • 0 comments

FDA approve AMOXICILLIN; CLAVULANATE POTASSIUM

Comment Full text
  • Previous
  • 1002
  • 1003
  • 1004
  • 1005
  • 1006
  • Next

Search

News categories

  • Technical Exchange News(12370)
  • Event(6229)
  • SEC News(272017)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158128)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin